Skip to Main Content

Author Details

Sabah Kadri
Abbvie Inc., Genomics Research Center
2009
52
20
PMIDPaper TitleJournal TitlePublished Year
36244574Recommendations for the Use of in Silico Approaches for Next-Generation Sequencing Bioinformatic Pipeline Validation: A Joint Report of the Association for Molecular Pathology, Association for Pathology Informatics, and College of American Pathologists.J Mol Diagn2023
36787117Optimization of Genomewide CRISPR Screens Using AsCas12a and Multi-Guide Arrays.CRISPR J2023
35189355Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology.J Mol Diagn2022
35830791Unified classification of mouse retinal ganglion cells using function, morphology, and gene expression.Cell Rep2022
36268089A performance evaluation study: Variant annotation tools - the enigma of clinical next generation sequencing (NGS) based genetic testing.J Pathol Inform2022
33960872The RNA structurome in the asexual blood stages of malaria pathogen <i>plasmodium falciparum</i>.RNA Biol2021
33608380Transcript analysis for variant classification resolution in a child with primary ciliary dyskinesia.Cold Spring Harb Mol Case Stud2021
34379075Genomic Autopsy of Sudden Deaths in Young Individuals.JAMA Cardiol2021
32276922Detailed Phenotypic and Functional Characterization of a Rare, Antibody-Dependent SLAM-Associated Protein Expression Pattern.Immunohorizons2020
31783043Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas.Hum Pathol2020
32074275A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.Blood Adv2020
32282345Follicular Thyroid Neoplasms: Comparison of Clinicopathologic and Molecular Features of Atypical Adenomas and Follicular Thyroid Carcinomas.Am J Surg Pathol2020
30273779insiM: in silico Mutator Software for Bioinformatics Pipeline Validation of Clinical Next-Generation Sequencing Assays.J Mol Diagn2019
31673932Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing.Mol Diagn Ther2019
31645901Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center.Oncotarget2019
31658273Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.PLoS One2019
30176755Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis.Int J Surg Pathol2019
31186530Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma.Mod Pathol2019
30986793Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma.Am J Surg Pathol2019
31054900Targeted mutational analysis of inflammatory bowel disease-associated colorectal cancers.Hum Pathol2019
30698790Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations.J Neuropathol Exp Neurol2019
30333224Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies.Clin Cancer Res2019
30557173Clinicopathologic and Molecular Features of Metastatic Follicular Thyroid Carcinoma in Patients Presenting With a Thyroid Nodule Versus a Distant Metastasis.Am J Surg Pathol2019
30635337Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma.Clin Cancer Res2019
28710706Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures.Endocr Pathol2018
35135165Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations.JCO Precis Oncol2018
30113886Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.J Clin Oncol2018
30425251Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.Nat Commun2018
30510142XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB.Mol Cancer Ther2018
28394804Risk factors, prevalence, and site concordance of human papillomavirus in high-risk Greek men.Eur J Cancer Prev2018
29728604Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.Nat Commun2018
29582677Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth.Arch Pathol Lab Med2018
29698836System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management.J Mol Diagn2018
29668487Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations?Am J Surg Pathol2018
29365323Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.Blood Adv2018
27855558Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).Leuk Lymphoma2017
28335028Defining the 5ο and 3ο landscape of the Drosophila transcriptome with Exo-seq and RNaseH-seq.Nucleic Acids Res2017
28348046B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.Clin Cancer Res2017
29296715Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.Blood Adv2017
28009605Melanotic PEComa of the Sinonasal Mucosa With NONO-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma.Am J Surg Pathol2017
27926791High prevalence of MiTF staining in undifferentiated pleomorphic sarcoma: caution in the use of melanocytic markers in sarcoma.Histopathology2017
27836695Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays.J Mol Diagn2017
26838501Evolutionary analysis across mammals reveals distinct classes of long non-coding RNAs.Genome Biol2016
26670585Polyglucosan bodies in intramuscular nerve branches are a poor predictor of GBE1 mutation and adult polyglucosan body disease.Muscle Nerve2016
27626698Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.Oncotarget2016
27173781Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block.Virchows Arch2016
26319364Amplicon Indel Hunter Is a Novel Bioinformatics Tool to Detect Large Somatic Insertion/Deletion Mutations in Amplicon-Based Next-Generation Sequencing Data.J Mol Diagn2015
24726434Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.Cell2014
25453760A negative feedback loop of transcription factors specifies alternative dendritic cell chromatin States.Mol Cell2014
23828888The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome.Science2013
  • 1 - 50 of 52

Recommended Authors

National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 0
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2014
Number of shared co-authors 0
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2014
Number of shared co-authors 1
The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 0
Tokyo Medical and Dental University
Career Start Year 2012
Number of shared co-authors 1
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 0
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 0
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 0
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 0
Simon Fraser University
Career Start Year 2005
Number of shared co-authors 1
University of Augsburg
Career Start Year 2004
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 2
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Uniformed Services University of the Health Sciences
Career Start Year 2004
Number of shared co-authors 2
Washington University
Career Start Year 2003
Number of shared co-authors 2
Washington University
Career Start Year 2003
Number of shared co-authors 2
University of California
Career Start Year 2003
Number of shared co-authors 0
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year 2003
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 4
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 0
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 9
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 0
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 2
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Career Start Year 1997
Number of shared co-authors 1
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 4
The Ohio State University
Career Start Year 1988
Number of shared co-authors 5

Collaborators

Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
The University of Chicago
Co-authored papers 2
University of Florida
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Children's Hospital Los Angeles
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
Houston Methodist Hospital
Co-authored papers 2
University of Cincinnati College of Medicine
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Weizmann Institute of Medical Sciences
Co-authored papers 1
Boston University
Co-authored papers 1
University of Chicago
Co-authored papers 1
Center for Genetic Medicine, Northwestern University Feinberg School of Medicine
Co-authored papers 1
Columbia University Irving Medical Center
Co-authored papers 1
Co-authored papers 1
Weizmann Institute of Science
Co-authored papers 1
National Institute of Standards and Technology
Co-authored papers 1
Co-authored papers 1
Broad Institute of MIT and Harvard
Co-authored papers 1
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Institute for Biomedical Informatics, University of Pennsylvania
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1
Co-authored papers 1
Feinberg School of Medicine, Northwestern University
Co-authored papers 1
Abbvie Inc., Genomics Research Center
Co-authored papers 1